Search for: "Ariad Pharmaceuticals Inc." Results 21 - 40 of 103
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Dec 2009, 3:40 pm by Patent Docs
§ 112, first paragraph, in an amicus curiae brief filed in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
14 Apr 2009, 9:59 pm
Judge Linn, at least, believes that is a doctrinal mistake, as he expressly stated in a concurring opinion in Ariad Pharmaceuticals, Inc. v. [read post]
6 Dec 2009, 9:59 pm
By Donald Zuhn -- In anticipation of tomorrow's oral argument in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
25 Nov 2009, 9:59 pm
Noonan -- The Intellectual Property Owners Association (IPO) has filed an amicus brief in the rehearing en banc of Ariad Pharmaceuticals, Inc. v. [read post]
24 Sep 2008, 4:59 am
ARIAD Pharmaceuticals Inc., Civil Action No. 06-cv-00259 (D. [read post]
7 Feb 2008, 8:48 pm
Del.) granted leave to Amgen Inc. to amend and supplement its reply to ARIAD Pharmaceuticals Inc.'s counterclaims to include new claims of inequitable conduct. [read post]
3 Apr 2009, 9:35 am
By Donald Zuhn -- This morning, the Federal Circuit issued decisions in both In re Kubin and Ariad Pharmaceuticals, Inc. v. [read post]
23 Aug 2009, 11:18 am
In an en banc order Friday, the Federal Circuit announced it will rehear Ariad Pharmaceuticals, Inc. v. [read post]
22 Mar 2010, 8:52 pm by Patent Docs
The en banc opinion addressed all of Ariad's arguments, and found in favor... [read post]
12 Apr 2009, 9:52 pm
Noonan -- Biotechnology patent law faces the consequences of two decisions handed down last week by the Federal Circuit: In re Kubin and Ariad Pharmaceuticals, Inc. v. [read post]
22 Mar 2010, 12:17 pm by Matt Osenga
Today, the Federal Circuit finally released its long-awaited opinion in Ariad Pharmaceuticals, Inc. v. [read post]
24 Mar 2010, 3:23 pm
Monday the Federal Circuit  released its en banc opinion in Ariad Pharmaceuticals, Inc. v. [read post]
22 Mar 2010, 9:15 pm by Patrick Richards
Earlier today, the Federal Circuit Court of Appeals published their en banc opinion in Ariad Pharmaceuticals, Inc. v. [read post]